{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:17:13Z","timestamp":1791357433878,"version":"4.3.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.schres.2017.11.010","type":"journal-article","created":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T14:30:10Z","timestamp":1510583410000},"page":"9-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis. A systematic review"],"prefix":"10.1016","volume":"197","author":[{"given":"Meghan","family":"Bowtell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aswin","family":"Ratheesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"McGorry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eoin","family":"Killackey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6240-6952","authenticated-orcid":false,"given":"Brian","family":"O'Donoghue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2017.11.010_bb0005","series-title":"Methods Guide for Effectiveness and Comparative Effectiveness Reviews. AHRQ Publication No. 10(14)-EHC063-EF","author":"Agency-for-Healthcare-Research-and-Quality","year":"2014"},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.11.010_bb0010","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.schres.2012.05.007","article-title":"Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies","volume":"139","author":"Alvarez-Jimenez","year":"2012","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.schres.2017.11.010_bb0015","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s40263-016-0331-x","article-title":"Beyond clinical remission in first episode psychosis: thoughts on antipsychotic maintenance vs. guided discontinuation in the functional recovery era","volume":"30","author":"Alvarez-Jimenez","year":"2016","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.schres.2017.11.010_bb0020","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1017\/S0033291700024247","article-title":"Predicting relapse in schizophrenia: the development and implementation of an early signs monitoring system using patients and families as observers, a preliminary investigation","volume":"19","author":"Birchwood","year":"1989","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.schres.2017.11.010_bb0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/schbul\/sbp116","article-title":"The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements","volume":"36","author":"Buchanan","year":"2010","journal-title":"Schizophr. Bull."},{"issue":"7770","key":"10.1016\/j.schres.2017.11.010_bb0030","first-page":"1","article-title":"Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trial","volume":"341","author":"Chen","year":"2010","journal-title":"BMJ[Br. Med. J.]"},{"key":"10.1016\/j.schres.2017.11.010_bb0035","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.schres.2016.12.029","article-title":"Predictors of favourable outcome in young people with a first episode psychosis without antipsychotic medication","volume":"185","author":"Conus","year":"2017","journal-title":"Schizophr. Res."},{"issue":"16","key":"10.1016\/j.schres.2017.11.010_bb0040","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2009.1549","article-title":"Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents","volume":"302","author":"Correll","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.schres.2017.11.010_bb0045","article-title":"The relapse rate and predictors of relapse in patients with first-episode psychosis following discontinuation of antipsychotic medication","author":"Di Capite","year":"2016","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.schres.2017.11.010_bb0050","doi-asserted-by":"crossref","DOI":"10.1038\/npjschz.2014.5","article-title":"Predictors of outcome in early-onset psychosis: a systematic review","volume":"1","author":"Diaz-Caneja","year":"2015","journal-title":"NPJ Schizophr."},{"key":"10.1016\/j.schres.2017.11.010_bb0055","series-title":"Australian Clinical Guidelines for Early Psychosis","author":"Early-Pychosis-Guidelines-Working-Group","year":"2010"},{"issue":"4","key":"10.1016\/j.schres.2017.11.010_bb0060","doi-asserted-by":"crossref","first-page":"e541","DOI":"10.4088\/JCP.11m07138","article-title":"Symptom recurrence following intermittent treatment in first-episode schizophrenia successfully treated for 2years: a 3-year open-label clinical study","volume":"73","author":"Emsley","year":"2012","journal-title":"J. Clin. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.11.010_bb0065","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.schres.2014.06.004","article-title":"A randomized, controlled trial of omega-3 fatty acids plus an antioxidant for relapse prevention after antipsychotic discontinuation in first-episode schizophrenia","volume":"158","author":"Emsley","year":"2014","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2017.11.010_bb0070","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/YCO.0000000000000249","article-title":"How long should antipsychotic treatment be continued after a single episode of schizophrenia?","volume":"29","author":"Emsley","year":"2016","journal-title":"Curr. Opin. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2017.11.010_bb0075","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1176\/appi.ps.201400558","article-title":"Early predictors of ten-year course in first-episode psychosis","volume":"67","author":"Friis","year":"2016","journal-title":"Psychiatr. Serv."},{"issue":"5","key":"10.1016\/j.schres.2017.11.010_bb0080","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.eurpsy.2012.08.002","article-title":"Outreach and support in south London (OASIS), 2001\u2013-2011: ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis","volume":"28","author":"Fusar-Poli","year":"2013","journal-title":"Eur. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2017.11.010_bb0085","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.neubiorev.2013.06.001","article-title":"Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies","volume":"37","author":"Fusar-Poli","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.11.010_bb0090","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2007.06.016","article-title":"Revisiting the relapse predictive validity of prodromal symptoms in schizophrenia","volume":"95","author":"Gaebel","year":"2007","journal-title":"Schizophr. Res."},{"issue":"Supplement(21)","key":"10.1016\/j.schres.2017.11.010_bb0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1192\/S0007125000292416","article-title":"Early neuroleptic intervention in schizophrenia: are prodromal symptoms valid predictors of relapse?","author":"Gaebel","year":"1993","journal-title":"Br. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2017.11.010_bb0100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4088\/JCP.09m05459yel","article-title":"Relapse prevention in first-episode schizophrenia\u2014maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia","volume":"72","author":"Gaebel","year":"2011","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2017.11.010_bb0105","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.schres.2015.10.024","article-title":"Predictors for symptom re-exacerbation after targeted stepwise drug discontinuation in first-episode schizophrenia: results of the first-episode study within the German research network on schizophrenia","volume":"170","author":"Gaebel","year":"2016","journal-title":"Schizophr. Res."},{"issue":"11","key":"10.1016\/j.schres.2017.11.010_bb0110","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1176\/appi.ajp.158.11.1835","article-title":"Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia","volume":"158","author":"Gitlin","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2017.11.010_bb0115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.schres.2005.07.019","article-title":"Early warning signs of relapse following a first episode of psychosis","volume":"80","author":"Gleeson","year":"2005","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2017.11.010_bb0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1017\/S003329170200675X","article-title":"Does treatment delay in first-episode psychosis really matter?","volume":"33","author":"Harrigan","year":"2003","journal-title":"Psychol. Med."},{"issue":"7","key":"10.1016\/j.schres.2017.11.010_bb0125","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1176\/ajp.137.7.801","article-title":"Relapse in schizophrenia","volume":"137","author":"Herz","year":"1980","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2017.11.010_bb0130","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.schres.2013.08.010","article-title":"Predicting 1-year risk for relapse in patients who have discontinued or continued quetiapine after remission from first-episode psychosis","volume":"150","author":"Hui","year":"2013","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2017.11.010_bb0135","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/eip.12099","article-title":"What needs to follow early intervention? Predictors of relapse and functional recovery following first-episode psychosis","volume":"9","author":"Kam","year":"2015","journal-title":"Early Interv. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2017.11.010_bb0140","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/archpsyc.1982.04290010048009","article-title":"Fluphenazine vs placebo in patients with remitted, acute first-episode schizophrenia","volume":"39","author":"Kane","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2017.11.010_bb0145","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1176\/appi.ajp.2015.15050632","article-title":"Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program","volume":"173","author":"Kane","year":"2016","journal-title":"Am. J. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.11.010_bb0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.schres.2016.01.046","article-title":"Predictors of discontinuation of antipsychotic medication and subsequent outcomes in the European First Episode Schizophrenia Trial (EUFEST)","volume":"172","author":"Landolt","year":"2016","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2017.11.010_bb0155","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.mp.4002136","article-title":"How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials","volume":"14","author":"Leucht","year":"2009","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2017.11.010_bb0160","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/070674371205700204","article-title":"Medication-adherent first-episode psychosis patients also relapse: why?","volume":"57","author":"Levy","year":"2012","journal-title":"Can. J. Psychiatr."},{"issue":"3 Suppl","key":"10.1016\/j.schres.2017.11.010_bb0165","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/0893-133X(95)00200-W","article-title":"Psychobiologic correlates of treatment response in schizophrenia","volume":"14","author":"Lieberman","year":"1996","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.schres.2017.11.010_bb0170","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/10398560903358846","article-title":"To medicate or not to medicate, when diagnosis is in question: decision-making in first episode psychosis","volume":"18","author":"Malhi","year":"2010","journal-title":"Australas. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2017.11.010_bb0175","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4088\/JCP.14m09540","article-title":"Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study","volume":"77","author":"Mayoral-van Son","year":"2016","journal-title":"J. Clin. Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2017.11.010_bb0180","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1176\/ajp.2007.164.7.1050","article-title":"Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison","volume":"164","author":"McEvoy","year":"2007","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2017.11.010_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001861","article-title":"Antipsychotic maintenance treatment: time to rethink?","volume":"12","author":"Moncrieff","year":"2015","journal-title":"PLoS Med."},{"issue":"13","key":"10.1016\/j.schres.2017.11.010_bb0190","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1017\/S0033291714000282","article-title":"Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study","volume":"44","author":"Morgan","year":"2014","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.schres.2017.11.010_bb0195","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/schbul\/21.4.527","article-title":"Prodromal symptoms of relapse in schizophrenia: a review","volume":"21","author":"Norman","year":"1995","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2017.11.010_bb0200","series-title":"Methods Guide for Effectiveness and Comparative Effectiveness Reviews","author":"Quality","year":"2008"},{"issue":"4","key":"10.1016\/j.schres.2017.11.010_bb0205","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.encep.2015.09.007","article-title":"Duration of untreated psychosis: a state-of-the-art review and critical analysis","volume":"42","author":"Souaiby","year":"2016","journal-title":"L'Enc\u00e9phale"},{"key":"10.1016\/j.schres.2017.11.010_bb0210","series-title":"Prescribing Guidelines in Psychiatry","author":"Taylor","year":"2011"},{"issue":"4","key":"10.1016\/j.schres.2017.11.010_bb0215","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/eip.12244","article-title":"Views of early psychosis clinicians on discontinuation of antipsychotic medication following symptom remission in first episode psychosis","volume":"10","author":"Thompson","year":"2016","journal-title":"Early Interv. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2017.11.010_bb0220","doi-asserted-by":"crossref","first-page":"654","DOI":"10.4088\/JCP.v68n0502","article-title":"Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome","volume":"68","author":"Wunderink","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"9","key":"10.1016\/j.schres.2017.11.010_bb0225","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jamapsychiatry.2013.19","article-title":"Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction\/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial","volume":"70","author":"Wunderink","year":"2013","journal-title":"JAMA Psychiat."},{"issue":"2\u20133","key":"10.1016\/j.schres.2017.11.010_bb0230","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.schres.2013.08.001","article-title":"Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review","volume":"152","author":"Zipursky","year":"2014","journal-title":"Schizophr. Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417306874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417306874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T18:46:05Z","timestamp":1720205165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996417306874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":46,"alternative-id":["S0920996417306874"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2017.11.010","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis. A systematic review","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2017.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}